A fusion protein structure enhances target peptide solubility through a cleavable linker design.
Thrombin cleaves a linker peptide in the SUMO fusion system to yield native GLP-2 analogs with high precision and cost efficiency.
SCHEMA recombination creates chimeric CBH I enzymes with enhanced thermostability and pH resistance, reducing enzyme loading costs during biomass conversion.